ArticleVirusdisease2025
Deciphering core genetic and pathway signatures of Japanese encephalitis virus using transcriptomics.
Article in Virusdisease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Japanese Encephalitis Virus (JEV), a mosquito-borne zoonotic pathogen, has a high mortality rate in Asia, causing severe neurological effects and fatalities in approximately 68,000 annual cases worldwide. Despite its prevalence, there is currently no specific treatment for JEV. This study leverages bioinformatics to identify potential molecular targets for therapeutic intervention. Data from three GEO profiles-GSE39740, GSE57330, and GSE115167-were retrieved from the NCBI-GEO database and analyzed for differentially expressed genes (DEGs) using the R simpleaffy package. Gene ontology and pathway enrichment analyses of the DEGs were conducted using clusterProfiler. Hub genes and disease networks were identified through Cytoscape, with functionally relevant clusters generated using MCODE and CytoHubba. Heatmaps and Volcano plots were used to visualize DEG regulation patterns. In the analysis, 1,601 DEGs were identified, comprising 1,103 upregulated and 498 downregulated genes. Among these, 37 hub genes were identified, with the top 10 being ACTB, ALB, CASP3, CDK4, CXCL10, CXCL8, CXCR4, DDX58, DICER1, and EGR1. Notably, ACTB emerged as the most connected node with a degree of 243. These hub genes represent promising therapeutic targets and enhance our understanding of JEV-related molecular pathways. The study's findings contribute significantly to the identification of biomarkers and therapeutic targets for the Japanese Encephalitis Virus, forming a foundation for further research to mitigate its severe impact on global health. Supplementary Information: The online version contains supplementary material available at 10.1007/s13337-025-00936-8.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.